Nick Diamond speaks about vaccine development at the National Vaccine Law Conference – Jackson Walker

0

On September 15, 2022, Jackson Walker partner Nicholas J. Diamond presented two sessions at the National Vaccine Law Conference held at George Mason University’s Antonin Scalia Law School.

The first session, “International Vaccine Law”, covered international structures for the development, regulation and distribution of vaccines. The presentation also touched on the topics of trade, supply chain issues and intellectual property barriers to vaccine development and access. Speakers include:

  • Fazal Khan (University of Georgia School of Law)
  • Clint Hermes (Bass, Berry & Sims)
  • Chizoba Wonodi (Head of Immunization Support Efforts at the Johns Hopkins Bloomberg School of Public Health Vaccine Access Center in Nigeria)
  • John D. Winter (Patterson Belknap)

The second session, “The Bright Future of Vaccine Development”, discusses the legal implications of vaccines being developed for conditions such as HIV, cancer, Parkinson’s disease, Alzheimer’s disease and drug addiction. Other panelists included:

  • Alexandra Bhatti (Director of US Vaccine Policy at Merck & Co. Inc)
  • Richard Hughes IV (GW Milken Institute School of Public Health)

To learn more, visit the National Vaccine Law Conference website.

Meet Nick

Nicholas J. Diamond is internationally recognized for his experience in vaccine law and public policy. He has extensive experience advising vaccine manufacturers in the US, APAC, Latin America and the EU on issues of regulation, public policy, government procurement and funding, liability and accountability. compensation, intellectual property and international trade. He has advised several vaccine manufacturers on very significant product launches in recent years. He has also advised other entities, such as payers and healthcare providers, including retail pharmacies, on vaccine-related issues regarding coverage and reimbursement, contracts, scope of practice, liability and public health emergency measures.

Nick is widely published internationally on issues spanning global health law, bioethics, business and human rights, public international law and international investment law. His writing has been published in law journals, peer-reviewed journals, and major media outlets, as well as discussed or featured in major outlets including The Washington Post, Slate, and Forbes. Nick has given guest lectures at various academic and industry forums, and appeared frequently as a commentator on national news networks, such as Bloomberg and MSNBC.

Share.

About Author

Comments are closed.